Warning
Shimoga Chemicals Recalls Clomiphene Citrate USP Active Pharmaceutical Ingredient
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0691-2026Drug / Pharmaceutical
Shimoga Chemicals Recalls Clomiphene Citrate USP Active Pharmaceutical Ingredient
Shimoga Chemicals · Class II — Moderate Risk
Product Description
Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01), b) 500 g (NDC 84849-000-02), (c) 100 g (NDC 84849-000-03), Rx Only, Shimoga Chemicals Address -W-57A, MIDC Kupwad Samgli, Maharashtra, 416436, India.
Reason for Recall
cGMP deviations
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
CA & FL only
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
Shimoga Chemicals has recalled a pharmaceutical product that the FDA classified as Class II. The recall was initiated on May 19, 2026. cGMP deviations. It was distributed in CA & FL only. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.